Marquet M - Search Results

1

High-yield production of pBR322-derived plasmids intended for human gene therapy by employing a temperature-controllable point mutation.

Lahijani R, Hulley G, Soriano G, Horn NA, Marquet M. Lahijani R, et al. Among authors: marquet m. Hum Gene Ther. 1996 Oct 20;7(16):1971-80. doi: 10.1089/hum.1996.7.16-1971. Hum Gene Ther. 1996. PMID: 8930657

2

Cancer gene therapy using plasmid DNA: purification of DNA for human clinical trials.

Horn NA, Meek JA, Budahazi G, Marquet M. Horn NA, et al. Among authors: marquet m. Hum Gene Ther. 1995 May;6(5):565-73. doi: 10.1089/hum.1995.6.5-565. Hum Gene Ther. 1995. PMID: 7578394

3

Quantitation of host cell DNA contaminate in pharmaceutical-grade plasmid DNA using competitive polymerase chain reaction and enzyme-linked immunosorbent assay.

Lahijani R, Duhon M, Lusby E, Betita H, Marquet M. Lahijani R, et al. Among authors: marquet m. Hum Gene Ther. 1998 May 20;9(8):1173-80. doi: 10.1089/hum.1998.9.8-1173. Hum Gene Ther. 1998. PMID: 9625256

4

Development and characterization of lyophilized DNA vaccine formulations.

Shen NL, Hartikka J, Horn NA, Manthorpe M, Marquet M. Shen NL, et al. Among authors: marquet m. Methods Mol Med. 2000;29:23-34. doi: 10.1385/1-59259-688-6:23. Methods Mol Med. 2000. PMID: 21374306

5

Plasmid DNA gene therapy: studies with the human interleukin-2 gene in tumor cells in vitro and in the murine B16 melanoma model in vivo.

Parker SE, Khatibi S, Margalith M, Anderson D, Yankauckas M, Gromkowski SH, Latimer T, Lew D, Marquet M, Manthorpe M, Hobart P, Hersh E, Stopeck AT, Norman J. Parker SE, et al. Among authors: marquet m. Cancer Gene Ther. 1996 May-Jun;3(3):175-85. Cancer Gene Ther. 1996. PMID: 8725882

6

An improved plasmid DNA expression vector for direct injection into skeletal muscle.

Hartikka J, Sawdey M, Cornefert-Jensen F, Margalith M, Barnhart K, Nolasco M, Vahlsing HL, Meek J, Marquet M, Hobart P, Norman J, Manthorpe M. Hartikka J, et al. Among authors: marquet m. Hum Gene Ther. 1996 Jun 20;7(10):1205-17. doi: 10.1089/hum.1996.7.10-1205. Hum Gene Ther. 1996. PMID: 8793545

7

Preclinical pharmacokinetics, manufacturing, and safety studies supporting a multicenter cancer gene therapy trial.

Norman JA, Parker S, Lew D, Manthorpe M, Marquet M. Norman JA, et al. Among authors: marquet m. Hum Gene Ther. 1995 May;6(5):549-50. doi: 10.1089/hum.1995.6.5-549. Hum Gene Ther. 1995. PMID: 7578391 No abstract available.

8

Genetic engineering of structural protein polymers.

Cappello J, Crissman J, Dorman M, Mikolajczak M, Textor G, Marquet M, Ferrari F. Cappello J, et al. Among authors: marquet m. Biotechnol Prog. 1990 May-Jun;6(3):198-202. doi: 10.1021/bp00003a006. Biotechnol Prog. 1990. PMID: 1366613

9

Direct gene transfer for treatment of human cancer.

Nabel GJ, Yang ZY, Nabel EG, Bishop K, Marquet M, Felgner PL, Gordon D, Chang AE. Nabel GJ, et al. Among authors: marquet m. Ann N Y Acad Sci. 1995 Nov 27;772:227-31. doi: 10.1111/j.1749-6632.1995.tb44748.x. Ann N Y Acad Sci. 1995. PMID: 8546397 Free article. Review.

10

[Automated surveillance and risk prediction with the aim of risk-stratified infection control and prevention (RISK PRINCIPE)].

Marschollek M, Marquet M, Reinoso Schiller N, Naim J, Aghdassi SJS, Behnke M, Ehrenberg S, von Landesberger T, Misailovski M, Prasser F, Scherag A, Schlueter D, Wulff A; RISK PRINCIPE Study Group; Pletz M, Scheithauer S. Marschollek M, et al. Among authors: marquet m. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2024 May 16. doi: 10.1007/s00103-024-03882-w. Online ahead of print. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2024. PMID: 38753020 Review. German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

78 results

Search Page